157 related articles for article (PubMed ID: 3047547)
21. Neurologic complications of pancreas transplants.
Kiok MC
Neurol Clin; 1988 May; 6(2):367-76. PubMed ID: 3047546
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
[TBL] [Abstract][Full Text] [Related]
23. Life-threatening neurological complications after bone marrow transplantation in children.
Uckan D; Cetin M; Yigitkanli I; Tezcan I; Tuncer M; Karasimav D; Oguz KK; Topçu M
Bone Marrow Transplant; 2005 Jan; 35(1):71-6. PubMed ID: 15531898
[TBL] [Abstract][Full Text] [Related]
24. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
Martin RW; Farmer ER; Altomonte VL; Vogelsang GB; Santos GW
Arch Dermatol; 1995 Mar; 131(3):333-5. PubMed ID: 7887664
[TBL] [Abstract][Full Text] [Related]
25. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
26. [Pulmonary complications after bone marrow transplantation].
Giacchino M; Busca A; Miniero R; Defilippi C; Massara FM; Vassallo E; Madon E
Minerva Pediatr; 1993 Apr; 45(4):141-50. PubMed ID: 8355644
[TBL] [Abstract][Full Text] [Related]
27. [Neurologic complications following liver transplantation].
Shibolet O; Safadi R; Ashur Y; Eid A; Ilan Y
Harefuah; 2002 Jan; 141(1):30-3, 127. PubMed ID: 11851103
[TBL] [Abstract][Full Text] [Related]
28. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Kalhs P; Brugger S; Schwarzinger I; Greinix HT; Keil F; Kyrle PA; Knöbl P; Schneider B; Höcker P; Linkesch W
Transplantation; 1995 Nov; 60(9):949-57. PubMed ID: 7491699
[TBL] [Abstract][Full Text] [Related]
29. Pattern of occurrence and clinical presentation of neurological complications in bone marrow transplant patients.
Furlong TG; Gallucci BB
Cancer Nurs; 1994 Feb; 17(1):27-36. PubMed ID: 8180974
[TBL] [Abstract][Full Text] [Related]
30. Management of dermatologic complications of chronic graft versus host disease: a case study.
DeMeyer ES; Fletcher MA; Buchsel PC
Clin J Oncol Nurs; 1997 Oct; 1(4):95-104. PubMed ID: 9410658
[TBL] [Abstract][Full Text] [Related]
31. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
Har-Noy M; Slavin S
Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
[TBL] [Abstract][Full Text] [Related]
32. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
33. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
34. Ocular manifestations in bone marrow transplantation.
Spires R
J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
[TBL] [Abstract][Full Text] [Related]
35. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
36. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
[TBL] [Abstract][Full Text] [Related]
37. Neurologic aspects of heart transplantation.
Heroux A; Pamboukian SV
Handb Clin Neurol; 2014; 121():1229-36. PubMed ID: 24365414
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
39. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
40. Spectrum and prognosis of neurologic complications after hematopoietic transplantation.
Denier C; Bourhis JH; Lacroix C; Koscielny S; Bosq J; Sigal R; Said G; Adams D
Neurology; 2006 Dec; 67(11):1990-7. PubMed ID: 17159106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
